Methylenedioxymethoxyethylamphetamine

MDMEOET, also known as 3,4-methylenedioxy-N-methoxyethylamphetamine, is a lesser-known drug and a substituted amphetamine.^[1] It is also the N-methoxyethyl analogue of MDA.^[1] MDMEOET was first synthesized by Alexander Shulgin.^[1] In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 180 mg.^[1] MDMEOET produces few to no effects.^[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMEOET.^[1]

MDMEOET

Clinical data
Other names	3,4-Methylenedioxy-N-methoxyethylamphetamine; MDMEOET; MDMEOETA
Routes of administration	Oral[1]
ATC code	None
Pharmacokinetic data
Duration of action	Unknown[1]
Identifiers
IUPAC name 1-(2H-1,3-benzodioxol-5-yl)-N-(2-methoxyethyl)propan-2-amine
CAS Number	74698-44-5 Y
PubChem CID	44719584
ChemSpider	21106334 N
UNII	YPA4B5U3U8
CompTox Dashboard (EPA)	DTXSID401348154 DTXSID10660371, DTXSID401348154
Chemical and physical data
Formula	C13H19NO3
Molar mass	237.299 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(Cc1ccc2c(c1)OCO2)NCCOC
InChI InChI=1S/C13H19NO3/c1-10(14-5-6-15-2)7-11-3-4-12-13(8-11)17-9-16-12/h3-4,8,10,14H,5-7,9H2,1-2H3 N Key:LOZJEWOZOKSOKA-UHFFFAOYSA-N N
NY (what is this?)  (verify)

Society and culture

Legal status

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.^[2]

See also

• Substituted methylenedioxyphenethylamine